Business Context and Reporting Period
This Form 8-K Current Report was filed by Bristol-Myers Squibb Company (BMS) on December 9, 2009. The filing addresses a temporary suspension of trading (blackout period) under the company's employee benefit plans. This action is connected to an anticipated offer to exchange 170.0 million shares of Mead Johnson Nutrition Company class A common stock for BMS common stock.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and employee benefit plan restrictions rather than financial performance.
Material Changes
The primary material change reported is the update to the anticipated blackout period dates for directors and executive officers. Initially, the blackout period was expected to begin on December 9, 2009. However, due to an extension of the Offer's expiration date from December 14, 2009, to December 17, 2009, the blackout period was rescheduled to begin on December 14, 2009, and end during the week of January 4, 2010.
Guidance, Outlook, and Risks
Management Commentary and Restrictions: The blackout period is triggered if 50% or more of participants in specific savings and investment plans tender their BMS shares held in the BMS Stock Fund. During this period, participants are restricted from exchanging account balances, obtaining distributions, withdrawals, or loans related to the BMS Stock Fund. Consequently, under Section 306(a) of the Sarbanes-Oxley Act and Regulation BTR, BMS directors and executive officers are prohibited from trading BMS shares or derivative securities during the blackout period and for two years following its conclusion.
Risks and Contingencies: The filing notes that the blackout period is contingent upon the tendering threshold being met by plan participants. The specific end date is tied to the week of January 4, 2010, subject to the Offer's timeline.
Key Facts for Investor Verification
- The blackout period for directors and executive officers is scheduled to begin on December 14, 2009, and end during the week of January 4, 2010.
- The restriction is linked to an exchange offer involving 170.0 million shares of Mead Johnson Nutrition Company stock.
- Trading restrictions apply to BMS shares and derivatives for directors and officers during the blackout period and for two years thereafter.
- Actual beginning and ending dates of the blackout period can be obtained from Sonia Vora, Senior Counsel & Assistant Corporate Secretary.